Ann: Mesoblast Maintains Momentum with FDA, page-76

  1. 311 Posts.
    lightbulb Created with Sketch. 167

    @stockrock
    "seems we could have a Revascor AA filing,
    adult Ryoncil trial recruiting (with very short timeframe endpoints i.e. 60-90 days)
    CLBP trial completing recruitment and
    Ryoncil sales ramp up to look forward to the second half of 2025…. i.e. in next 6 months.

    that’s a nice pipeline and we are still trading below pre-approval levels"

    These two sentences summarise the whole situation, current and for next 6 months.


    Last edited by bontz777: Thursday, 15:31
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.84
Change
0.048(2.65%)
Mkt cap ! $2.376B
Open High Low Value Volume
$1.83 $1.88 $1.83 $3.312M 1.785M

Buyers (Bids)

No. Vol. Price($)
11 17185 $1.84
 

Sellers (Offers)

Price($) Vol. No.
$1.85 26816 19
View Market Depth
Last trade - 11.00am 16/06/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.